Portal de Periódicos da CAPES

Rhabdomyolysis after low‐dose quetiapine in a patient with Parkinson's disease with drug‐induced psychosis: A case report

2010; Wiley; Volume: 25; Issue: 6 Linguagem: Inglês

10.1002/mds.23015

1531-8257

Caspar Stephani, Claudia Trenkwalder,

Bipolar Disorder and Treatment

Movement DisordersVolume 25, Issue 6 p. 790-791 Letter to the Editor Rhabdomyolysis after low-dose quetiapine in a patient with Parkinson's disease with drug-induced psychosis: A case report† Caspar Stephani MD, Corresponding Author Caspar Stephani MD [email protected] Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany Centre for Parkinsonism and Movement Disorders, Paracelsus-Elena Hospital, Kassel, GermanyDepartment of Clinical Neurophysiology, University of Goettingen, Goettingen, GermanySearch for more papers by this authorClaudia Trenkwalder MD, PhD, Claudia Trenkwalder MD, PhD Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany Centre for Parkinsonism and Movement Disorders, Paracelsus-Elena Hospital, Kassel, GermanySearch for more papers by this author Caspar Stephani MD, Corresponding Author Caspar Stephani MD [email protected] Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany Centre for Parkinsonism and Movement Disorders, Paracelsus-Elena Hospital, Kassel, GermanyDepartment of Clinical Neurophysiology, University of Goettingen, Goettingen, GermanySearch for more papers by this authorClaudia Trenkwalder MD, PhD, Claudia Trenkwalder MD, PhD Department of Clinical Neurophysiology, University of Goettingen, Goettingen, Germany Centre for Parkinsonism and Movement Disorders, Paracelsus-Elena Hospital, Kassel, GermanySearch for more papers by this author First published: 26 April 2010 https://doi.org/10.1002/mds.23015Citations: 11 † Potential conflict of interest: Nothing to report. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Pasternak RC,Smith SC,Bairey-Merz CN,Grundy SM,Cleeman JI,Lenfant C. ACC/AHA/NHLBI clinical advisory on the use and safety of statins. J Am Coll Cardiol 2002; 40: 567–572. 2 Strawn JR,Keck PE,Caroff SN. Neuroleptic malignant syndrome. Am J Psychiatry 2007; 164: 870–876. 3 Takubo H,Harada T,Hashimoto T, et al. A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 2003; 9 ( Suppl 1): 31–41. 4 Melli G,Chaudhry V,Cornblath DR. Rhabdomyolysis—an evaluation of 475 hospitalized patients. Medicine 2005; 84: 377–385. 5 Devarajan S,Dursun SM. Antipsychotic drugs, serum creatine kinase (CPK), and possible mechanisms. Psychopharmacology 2000; 152: 122. 6 Rabus SA,Izzettin F,Rabus M,Bilici M. Severe creatine kinase increase during quetiapine and mirtazapine treatment. Psychopharmacology 2006; 185: 263–264. 7 Klein JP,Fiedler U,Appel H,Quante A,Jockers-Scherübl MC. Massive creatine kinase elevations with quetiapine: report of two cases. Pharmacopsychiatry 2006; 39: 39–40. 8 Himmerich H,Ehrlinger M,Hackenberg M,Löhr B,Nickel T. Possible case of a quetiapine induced rhabdomyolysis in a patient with depression treated with fluoxetine. J Clin Psychopharmacol 2006; 26: 676–677. 9 Kapur S,Seeman P. Does fast dissociation from the dopamine D2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 2001; 158: 360–369. 10 Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol Toxicol 2007; 47: 513–539. 11 Harper CR,Jacobson TA. The broad spectrum of statin myopathy: from myalgia to rhabdomyolysis. Curr Opin Lipidol 2007; 18: 401–408. 12 Casademont J,Garrabou G,Miró Ò, et al. Neuroleptic treatment effect on mitochondrial electron transport chain. J Clin Psychopharmacol 2007; 27: 284–288. 13 Melkersson K. Serum creatine kinase levels in chronic psychosis patients—a comparison between atypical and conventional antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2002; 30: 1277–1282. 14 Meltzer HY. Massive serum creatine kinase increases with atypical antipsychotic drugs: what is the mechanism and the message? Psychopharmacology 2000; 150: 349–350. Citing Literature Volume25, Issue630 April 2010Pages 790-791 ReferencesRelatedInformation